Latest Excessive daytime sleepiness Stories
Trial Initiated in Response to a FDA Pediatric Written Request to Study Xyrem in Children and Adolescents DUBLIN, Dec.
$30,000 Grant to Dr. Thomas Scammell Supports Ongoing Search for Narcolepsy Cure WORCESTER, Mass., Dec. 1, 2014 /PRNewswire-USNewswire/ -- Wake Up Narcolepsy, Inc.
WORCESTER, Mass., Nov.
Nonprofit Continues Support in the Search for Narcolepsy Cure WORCESTER, Mass., July 3, 2014 /PRNewswire-USNewswire/ -- Wake Up Narcolepsy, Inc.
Study Demonstrated Robust Alerting Effect Consistent with Phase 2a Results DUBLIN, June 2, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented data from the Phase 2b
Phase 2b Data for JZP-110 in Adults with EDS in Narcolepsy Accepted as Late-Breaker Oral Presentation DUBLIN, May 27, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced
Eduardo Benarroch, M.D. of the Mayo Clinic in Rochester, MN.
Terms include $125 million upfront payment in cash plus a potential of up to $272 million in milestone payments DUBLIN, Jan.
Historic FDA meeting on narcolepsy drug development brings narcolepsy community to FDA to offer candid and emotional remarks on how narcolepsy affects their lives, and on current treatment options.
- The act of sweetening by admixture of some saccharine substance.